{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T18:48:41Z","timestamp":1790707721938,"version":"4.1.0"},"reference-count":29,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2016,4,1]],"date-time":"2016-04-01T00:00:00Z","timestamp":1459468800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,4,1]],"date-time":"2016-04-01T00:00:00Z","timestamp":1459468800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["annalsthoracicsurgery.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Annals of Thoracic Surgery"],"published-print":{"date-parts":[[2016,4]]},"DOI":"10.1016\/j.athoracsur.2015.10.044","type":"journal-article","created":{"date-parts":[[2016,1,12]],"date-time":"2016-01-12T10:18:28Z","timestamp":1452593908000},"page":"1361-1369","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":57,"title":["Clinicopathologic and Prognostic Implications of Programmed Death Ligand 1 Expression in Thymoma"],"prefix":"10.1016","volume":"101","author":[{"given":"Shintaro","family":"Yokoyama","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroaki","family":"Miyoshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatsuya","family":"Nishi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshihiro","family":"Hashiguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahiro","family":"Mitsuoka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinzo","family":"Takamori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshito","family":"Akagi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatsuyuki","family":"Kakuma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koichi","family":"Ohshima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10 Suppl 4","key":"10.1016\/j.athoracsur.2015.10.044_bib1","doi-asserted-by":"crossref","first-page":"S304","DOI":"10.1097\/JTO.0b013e3181f20c05","article-title":"Staging system of thymoma","volume":"5","author":"Masaoka","year":"2010","journal-title":"J\u00a0Thorac Oncol"},{"key":"10.1016\/j.athoracsur.2015.10.044_bib2","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1055\/s-0030-1271010","article-title":"Surgical resection of thymoma still represents the first choice of treatment","volume":"60","author":"Ried","year":"2012","journal-title":"Thorac Cardiovasc Surg"},{"issue":"7 Suppl 3","key":"10.1016\/j.athoracsur.2015.10.044_bib3","doi-asserted-by":"crossref","first-page":"S1749","DOI":"10.1097\/JTO.0b013e31821ea5f7","article-title":"Chemotherapy definitions and policies for thymic malignancies","volume":"6","author":"Girard","year":"2011","journal-title":"J\u00a0Thorac Oncol"},{"issue":"10 Suppl 4","key":"10.1016\/j.athoracsur.2015.10.044_bib4","doi-asserted-by":"crossref","first-page":"S357","DOI":"10.1097\/JTO.0b013e3181f21129","article-title":"The role of chemotherapy in advanced thymoma","volume":"5","author":"Schmitt","year":"2010","journal-title":"J\u00a0Thorac Oncol"},{"key":"10.1016\/j.athoracsur.2015.10.044_bib5","doi-asserted-by":"crossref","first-page":"3462","DOI":"10.1158\/1078-0432.CCR-13-0855","article-title":"PD-L1 expression is characteristic of a subset of aggressive B-cell lymphomas and virus-associated malignancies","volume":"19","author":"Chen","year":"2013","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.athoracsur.2015.10.044_bib6","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.clim.2014.04.010","article-title":"Programmed death-1 pathway in cancer and autoimmunity","volume":"153","author":"Pedoeem","year":"2014","journal-title":"Clin Immunol"},{"key":"10.1016\/j.athoracsur.2015.10.044_bib7","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1038\/70932","article-title":"B7-H1, a third member of the B7 family, co-stimulates T-cell proliferation and interleukin-10 secretion","volume":"5","author":"Dong","year":"1999","journal-title":"Nat Med"},{"key":"10.1016\/j.athoracsur.2015.10.044_bib8","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1093\/intimm\/dxu095","article-title":"Therapeutic uses of anti-PD-1 and anti-PD-L1 antibodies","volume":"27","author":"Philips","year":"2015","journal-title":"Int Immunol"},{"key":"10.1016\/j.athoracsur.2015.10.044_bib9","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1007\/s11864-013-0268-y","article-title":"Potential of new therapies like anti-PD1 in kidney cancer","volume":"15","author":"Gunturi","year":"2014","journal-title":"Curr Treat Options Oncol"},{"key":"10.1016\/j.athoracsur.2015.10.044_bib10","series-title":"Pathology and genetics: tumours of the lung, pleura, thymus and heart","first-page":"145","author":"Travis","year":"2004"},{"key":"10.1016\/j.athoracsur.2015.10.044_bib11","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/j.bbrc.2013.06.093","article-title":"Radiation-induced nitric oxide mitigates tumor hypoxia and radioresistance in a murine SCCVII tumor model","volume":"437","author":"Nagane","year":"2013","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.athoracsur.2015.10.044_bib12","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1111\/j.1651-2227.2006.00178.x","article-title":"Understanding diagnostic tests 3: receiver operating characteristic curves","volume":"96","author":"Akobeng","year":"2007","journal-title":"Acta Paediatr"},{"key":"10.1016\/j.athoracsur.2015.10.044_bib13","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1016\/j.humpath.2009.03.025","article-title":"Increased programmed death-1+ tumor-infiltrating lymphocytes in classical Hodgkin lymphoma substantiate reduced overall survival","volume":"40","author":"Muenst","year":"2009","journal-title":"Hum Pathol"},{"key":"10.1016\/j.athoracsur.2015.10.044_bib14","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1097\/JTO.0000000000000215","article-title":"Prognostic factors for cure, recurrence and long-term survival after surgical resection of thymoma","volume":"9","author":"Safieddine","year":"2014","journal-title":"J\u00a0Thorac Oncol"},{"issue":"7 Suppl 3","key":"10.1016\/j.athoracsur.2015.10.044_bib15","doi-asserted-by":"crossref","first-page":"S1698","DOI":"10.1097\/JTO.0b013e31821e7b12","article-title":"A\u00a0review of prognostic factors in thymic malignancies","volume":"6","author":"Detterbeck","year":"2011","journal-title":"J\u00a0Thorac Oncol"},{"key":"10.1016\/j.athoracsur.2015.10.044_bib16","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1002\/cncr.10226","article-title":"The World Health Organization histologic classification system reflects the oncologic behavior of thymoma: a clinical study of 273 patients","volume":"94","author":"Okumura","year":"2002","journal-title":"Cancer"},{"key":"10.1016\/j.athoracsur.2015.10.044_bib17","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1177\/0036933013518147","article-title":"Outcome in excised thymomas: role of prognostic factors and impact of additional malignancies on survival","volume":"59","author":"Granato","year":"2014","journal-title":"Scott Med J"},{"key":"10.1016\/j.athoracsur.2015.10.044_bib18","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1093\/ejcts\/ezu368","article-title":"Does the World Health Organization histological classification predict outcomes after thymomectomy? Results of a multicentre study on 750 patients","volume":"48","author":"Guerrera","year":"2015","journal-title":"Eur J Cardiothorac Surg"},{"key":"10.1016\/j.athoracsur.2015.10.044_bib19","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1038\/modpathol.2010.172","article-title":"WHO types A and AB thymomas: not always benign","volume":"23","author":"Jain","year":"2010","journal-title":"Mod Pathol"},{"key":"10.1016\/j.athoracsur.2015.10.044_bib20","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1097\/00000478-199812000-00004","article-title":"Thymic carcinoma arising in thymoma is associated with alterations in immunohistochemical profile","volume":"22","author":"Kuo","year":"1998","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.athoracsur.2015.10.044_bib21","doi-asserted-by":"crossref","first-page":"567","DOI":"10.2147\/OTT.S59959","article-title":"Protein expression of programmed death 1 ligand 1 and ligand 2 independently predict poor prognosis in surgically resected lung adenocarcinoma","volume":"7","author":"Zhang","year":"2014","journal-title":"Onco Targets Ther"},{"key":"10.1016\/j.athoracsur.2015.10.044_bib22","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1097\/JTO.0000000000000429","article-title":"Diffuse high intensity PD-L1 staining in thymic epithelial tumors","volume":"10","author":"Padda","year":"2015","journal-title":"J\u00a0Thorac Oncol"},{"key":"10.1016\/j.athoracsur.2015.10.044_bib23","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.lungcan.2015.03.003","article-title":"Immunohistochemical status of PD-L1 in thymoma and thymic carcinoma","volume":"88","author":"Katsuya","year":"2015","journal-title":"Lung Cancer"},{"key":"10.1016\/j.athoracsur.2015.10.044_bib24","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1016\/j.jaad.2014.01.880","article-title":"Expression of programmed death receptor ligand 1 in melanoma may indicate tumor progression and poor patient survival","volume":"70","author":"Oba","year":"2014","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.athoracsur.2015.10.044_bib25","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1007\/s00262-006-0266-z","article-title":"Overexpression of B7-H1 (PD-L1) significantly associates with tumor grade and postoperative prognosis in human urothelial cancers","volume":"56","author":"Nakanishi","year":"2007","journal-title":"Cancer Immunol Immunother"},{"key":"10.1016\/j.athoracsur.2015.10.044_bib26","doi-asserted-by":"crossref","first-page":"3581","DOI":"10.4049\/jimmunol.169.7.3581","article-title":"B7-H1 is expressed by human endothelial cells and suppresses T cell cytokine synthesis","volume":"169","author":"Mazanet","year":"2002","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.athoracsur.2015.10.044_bib27","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1038\/nm730","article-title":"Tumor-associated B7-H1 promotes T-cell apoptosis: a potential mechanism of immune evasion","volume":"8","author":"Dong","year":"2002","journal-title":"Nat Med"},{"key":"10.1016\/j.athoracsur.2015.10.044_bib28","doi-asserted-by":"crossref","first-page":"2062","DOI":"10.1182\/blood-2013-10-535443","article-title":"Genomic rearrangements involving programmed death ligands are recurrent in primary mediastinal large B-cell lymphoma","volume":"123","author":"Twa","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.athoracsur.2015.10.044_bib29","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.4049\/jimmunol.170.3.1257","article-title":"Blockade of programmed death-1 ligands on dendritic cells enhances T cell activation and\u00a0cytokine production","volume":"170","author":"Brown","year":"2003","journal-title":"J\u00a0Immunol"}],"container-title":["The Annals of Thoracic Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003497515017154?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003497515017154?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T03:31:40Z","timestamp":1757734300000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003497515017154"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,4]]},"references-count":29,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2016,4]]}},"alternative-id":["S0003497515017154"],"URL":"https:\/\/doi.org\/10.1016\/j.athoracsur.2015.10.044","relation":{},"ISSN":["0003-4975"],"issn-type":[{"value":"0003-4975","type":"print"}],"subject":[],"published":{"date-parts":[[2016,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinicopathologic and Prognostic Implications of Programmed Death Ligand 1 Expression in Thymoma","name":"articletitle","label":"Article Title"},{"value":"The Annals of Thoracic Surgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.athoracsur.2015.10.044","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 The Society of Thoracic Surgeons. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}